Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hemangiosarcoma × Docetaxel × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 15 Squamous Cell Carcinoma of Head and Neck 7 Breast Neoplasms 7 Prostatic Neoplasms 5 Lung Neoplasms 5 Urinary Bladder Neoplasms 4 Prostatic Neoplasms, Castration-Resistant 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Laryngeal Neoplasms 3 Carcinoma, Transitional Cell 3 Salivary Gland Neoplasms 2 Oropharyngeal Neoplasms 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Metastatic Castration-Resistant Prostate Cancer 2 Lymphoid Interstitial Pneumonia 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Adenocarcinoma Of Esophagus 2 Vaccinia 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Tongue Neoplasms 1 Thyroid Neoplasms 1 Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1

Interventions

pembrolizumab 2 Standard of Care 2 Paclitaxel 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 talazoparib 1 sarilumab 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 durvalumab 1 dostarlimab 1 cemiplimab 1 abemaciclib 1 Trastuzumab 1 Specimen Handling 1 STA 9090 1 SGN-LIV1A 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 MK 2206 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡